Spoken Alpha · Executive

Michael S Abrams

Chief Financial OfficerNRXPNRX Pharmaceuticals, Inc.

In our data from Nov 18, 2024

Tracked across 15 earnings calls in our data since 2024.

Role timeline

NRXPNRX Pharmaceuticals, Inc.
Chief Financial Officer
Nov 18, 2024 – Feb 7, 2025 · source: edgar_form4
NRXPWNRX Pharmaceuticals, Inc.
Chief Financial Officer
Nov 18, 2024 – Feb 7, 2025 · source: edgar_form4
ABUSArbutus Biopharma Corp
Managing Director
Jul 9, 2015 – Sep 30, 2016 · source: edgar_form4
ABUSArbutus Biopharma Corp
Exec. VP & Chief Discovery Off
Mar 30, 2015 – Jul 9, 2015 · source: edgar_form4
FTLFFITLIFE BRANDS, INC.
CHIEF FINANCIAL OFFICER
Feb 23, 2015 – Dec 31, 2016 · source: edgar_form5

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

15 calls

NRXPQ2 FY2026Aug 17, 2026

NRX Pharmaceuticals, Inc.

NRXPQ1 FY2026May 18, 2026

NRX Pharmaceuticals, Inc.

NRXPWQ1 FY2026May 18, 2026

NRX Pharmaceuticals, Inc.

NRXPWQ4 FY2025Mar 24, 2026

NRX Pharmaceuticals, Inc.

NRXPQ4 FY2025Mar 24, 2026

NRX Pharmaceuticals, Inc.